Abstract
Glycoproteins derived from Hansenula polymorpha can not be used for therapeutic purposes due to their high-mannose type asparagine-linked (N-linked) glycans, which result in immune reactions and poor pharmacokinetic behaviors in human body. Previously, we reported that the trimannosyl core N-linked glycans (Man3GlcNAc2) intermediate can be generated in endoplasmic reticulum in HpALG3 and HpALG11 double-mutant H. polymorpha. Here, we describe the further modification of the glycosylation pathway in this double-defect strain to express glycoproteins with complex human-like glycans. After eliminating the impact of HpOCH1, three glycosyltransferases were introduced into this triple-mutant strain. When human β-1,2-N-acetylglucosaminyltransferase I (hGnTI) was efficiently targeted in early Golgi, more than 95 % glycans attached to the glycoproteins were added one N-acetylglucosamine (GlcNAc). With subsequently introduction of rat β-1,2-N-acetylglucosaminyltransferase II (rGnTII) and human β-1,4-galactosyltransferase I (hGalTI), several glycoengineered strains can produce glycoproteins bearing glycans with terminal N-acetylglucosamine or galactose. The expression of glycoproteins with glycan Gal2GlcNAc2Man3GlcNAc2 represents a significant step toward the ability to express fully humanized glycoproteins in H. polymorpha. Furthermore, several shake-flask and bioreactor fermentation experiments indicated that, although the cells do display a reduction in growth rate, the glycoengineered strains are still suitable for high-density fermentation.
Similar content being viewed by others
References
Abe H, Takaoka Y, Chiba Y, Sato N, Ohgiya S et al (2009) Development of valuable yeast strains using a novel mutagenesis technique for the effective production of therapeutic glycoproteins. Glycobiology 19(4):428–436
Ballou C (1990) Isolation, characterization, and properties of Saccharomyces cerevisiae mnn mutants with nonconditional protein glycosylation defects. Method Enzymol 185:440–470
Bobrowicz P, Davidson RC, Li H, Potgieter TI, Nett JH et al (2004) Engineering of an artificial glycosylation pathway blocked in core oligosaccharide assembly in the yeast Pichia pastoris: production of complex humanized glycoproteins with terminal galactose. Glycobiology 14(9):757–766
Burda P, Aebi M (1999) The dolichol pathway of N-linked glycosylation. Biochim Biophys Acta 1426(2):239–257
Cheng J, Huang S, Yu H, Li Y, Lau K et al (2010) Trans-sialidase activity of Photobacterium damsela α2, 6-sialyltransferase and its application in the synthesis of sialosides. Glycobiology 20(2):260–268
Cheon SA, Kim H, Oh DB, Kwon O, Kang HA (2012) Remodeling of the glycosylation pathway in the methylotrophic yeast Hansenula polymorpha to produce human hybrid-type N-glycans. J Microbiol 50(2):341–348
Chiba Y, Suzuki M, Yoshida S, Yoshida A, Ikenaga H et al (1998) Production of human compatible high mannose-type (Man5GlcNAc2) sugar chains in Saccharomyces cerevisiae. J Biol Chem 273(41):26298–26304
D’Agostaro GA, Zingoni A, Moritz RL, Simpson RJ, Schachter H et al (1995) Molecular cloning and expression of cDNA encoding the rat UDP-N-acetylglucosamine: alpha-6-D-mannoside beta-1, 2-N-acetylglucosaminyltransferase II. J Biol Chem 270(25):15211–15221
De Pourcq K, De Schutter K, Callewaert N (2010) Engineering of glycosylation in yeast and other fungi: current state and perspectives. Appl Microbiol Biotechnol 87(5):1617–1631
Dean N (1999) Asparagine-linked glycosylation in the yeast Golgi. Biochim Biophys Acta 1426(2):309–322
Freeze HH (2006) Genetic defects in the human glycome. Nat Rev Genet 7(7):537–551
Friedman BA, Vaddi K, Preston C, Mahon E, Cataldo JR et al (1999) A comparison of the pharmacological properties of carbohydrate remodeled recombinant and placental-derived β-glucocerebrosidase: implications for clinical efficacy in treatment of Gaucher disease. Blood 93(9):2807–2816
Gellissen G, Kunze G, Gaillardin C, Cregg JM, Berardi E et al (2005) New yeast expression platforms based on methylotrophic Hansenula polymorpha and Pichia pastoris and on dimorphic Arxula adeninivorans and Yarrowia lipolytica-a comparison. FEMS Yeast Res 5(11):1079–1096
Gemmill TR, Trimble RB (1999) Overview of N- and O-linked oligosaccharide structures found in various yeast species. Biochim Biophys Acta 1426(2):227–237
Hamilton SR, Bobrowicz P, Bobrowicz B, Davidson RC, Li H et al (2003) Production of complex human glycoproteins in yeast. Science 301(5637):1244–1246
Hamilton SR, Davidson RC, Sethuraman N, Nett JH, Jiang Y et al (2006) Humanization of yeast to produce complex terminally sialylated glycoproteins. Science 313(5792):1441–1443
Helenius A, Aebi M (2001) Intracellular functions of N-linked glycans. Science 291(5512):2364–2369
Ishchuk OP, Voronovsky AY, Abbas CA, Sibirny AA (2009) Construction of Hansenula polymorpha strains with improved thermotolerance. Biotechnol Bioeng 104(5):911–919
Kang HA, Sohn JH, Choi ES, Chung BH, Yu MH et al (1998) Glycosylation of human α1-antitrypsin in Saccharomyces cerevisiae and methylotrophic yeasts. Yeast 14(4):371–381
Kiel J, Komduur J, van der Klei I, Veenhuis M (2003) Macropexophagy in Hansenula polymorpha: facts and views. FEBS Lett 549(1–3):1–6
Kim MW, Rhee SK, Kim JY, Shimma Y, Chiba Y et al (2004) Characterization of N-linked oligosaccharides assembled on secretory recombinant glucose oxidase and cell wall mannoproteins from the methylotrophic yeast Hansenula polymorpha. Glycobiology 14(3):243–251
Kim MW, Kim EJ, Kim JY, Park JS, Oh DB et al (2006) Functional characterization of the Hansenula polymorpha HOC1, OCH1, and OCR1 genes as members of the yeast OCH1 mannosyltransferase family involved in protein glycosylation. J Biol Chem 281(10):6261–6272
Kunze G, Kang HA, Gellissen G (2009) Hansenula polymorpha (Pichia angusta): biology and applications. In: Satyanaayana T, Kunze G (eds) Yeast biotechnology:diversity and applications. Springer, Berlin, pp 47–64
Li H, Sethuraman N, Stadheim TA, Zha D, Prinz B et al (2006) Optimization of humanized IgGs in glycoengineered Pichia pastoris. Nat Biotechnol 24(2):210–215
Matsumiya S, Yamaguchi Y, Saito J, Nagano M, Sasakawa H et al (2007) Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1. J Mol Biol 368(3):767–779
Moremen KW, Tiemeyer M, Nairn AV (2012) Vertebrate protein glycosylation: diversity, synthesis and function. Nat Res Mol Cell Biol 13(7):448–462
Nett JH, Stadheim TA, Li H, Bobrowicz P, Hamilton SR et al (2011) A combinatorial genetic library approach to target heterologous glycosylation enzymes to the endoplasmic reticulum or the Golgi apparatus of Pichia pastoris. Yeast 28(3):237–252
Oh DB, Park JS, Kim MW, Cheon SA, Kim EJ et al (2008) Glycoengineering of the methylotrophic yeast Hansenula polymorpha for the production of glycoproteins with trimannosyl core N-glycan by blocking core oligosaccharide assembly. Biotechnol J 3(5):659–668
Qian W, Song H, Liu Y, Zhang C, Niu Z et al (2009) Improved gene disruption method and Cre-loxP mutant system for multiple gene disruptions in Hansenula polymorpha. J Microbiol Methods 79(3):253–259
Sethuraman N, Stadheim TA (2006) Challenges in therapeutic glycoprotein production. Curr Opin Biotechnol 17(4):341–346
Song H, Qian W, Wang H, Qiu B (2010) Identification and functional characterization of the HpALG11 and the HpRFT1 genes involved in N-linked glycosylation in the methylotrophic yeast Hansenula polymorpha. Glycobiology 20(12):1665–1674
Stöckmann C, Maier U, Anderlei T, Knocke C, Gellissen G et al (2003) The oxygen transfer rate as key parameter for the characterization of Hansenula polymorpha screening cultures. J Ind Microbiol Biot 30(10):613–622
Stöckmann C, Scheidle M, Dittrich B, Merckelbach A, Hehmann G et al (2009) Process development in Hansenula polymorpha and Arxula adeninivorans, a re-assessment. Microb Cell Fact. doi:10.1186/1475-2859-8-22
Umana P, Jean-Mairet J, Moudry R, Amstutz H, Bailey JE (1999) Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat Biotechnol 17(2):176–180
Verostek MF, Lubowski C, Trimble RB (2000) Selective organic precipitation/extraction of released N-glycans following large-scale enzymatic deglycosylation of glycoproteins. Anal Biochem 278(2):111–122
Vervecken W, Kaigorodov V, Callewaert N, Geysens S, De Vusser K et al (2004) In vivo synthesis of mammalian-like, hybrid-type N-glycans in Pichia pastoris. Appl Environ Microbiol 70(5):2639–2646
Werten MWT, van den Bosch TJ, Wind RD, Mooibroek H, de Wolf FA (1999) High-yield secretion of recombinant gelatins by Pichia pastoris. Yeast 15(11):1087–1096
Acknowledgments
We gratefully acknowledge the MALDI-TOF assistance provided by Dr. Yuan-ming Luo (Institute of Microbiology, Chinese Academy of Sciences, Beijing, China).
Conflict of interest
The authors report no potential conflicts of interest in this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, H., Song, Hl., Wang, Q. et al. Expression of glycoproteins bearing complex human-like glycans with galactose terminal in Hansenula polymorpha . World J Microbiol Biotechnol 29, 447–458 (2013). https://doi.org/10.1007/s11274-012-1197-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11274-012-1197-9